Patients' preferences for selection of endpoints in cardiovascular clinical trials
Background: To reduce the duration and overall costs of cardiovascular trials, use of the combined endpoints in trial design has become commonplace. Though this methodology may serve the needs of investigators and trial sponsors, the preferences of patients or potential trial subjects in the trial d...
Saved in:
Main Authors: | Robert D. Chow (Author), Kashmira P. Wankhedkar (Author), Mihriye Mete (Author) |
---|---|
Format: | Book |
Published: |
Greater Baltimore Medical Center,
2014-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Trial Risk in Non-Hodgkin's Lymphoma: Endpoint and Target Selection
by: Jayson Lee Parker, et al.
Published: (2011) -
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
by: Michael S. Yule, et al.
Published: (2024) -
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
by: Marianne J. Hjermstad, et al.
Published: (2024) -
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
by: James McDonald, et al.
Published: (2023) -
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
by: Ola Magne Vagnildhaug, et al.
Published: (2024)